FDA updates patient and provider fact sheets for mRNA COVID-19 vaccines; revises bronchoscope reprocessing safety recommendations

The Food and Drug Administration June 25 formally updated its patient and provider fact sheets for the Moderna and Pfizer COVID-19 vaccines to include warnings about the increased risk of heart inflammation in patients.

FDA also revised its safety recommendations for bronchoscope reprocessing. The agency now recommends health care facilities and staff consider sterilization over high-level disinfection when reprocessing. Other requests include not using damaged devices or those that have failed a leak test and performing preventive maintenance and proper inspection of bronchoscopes